Description

Urticaria or Hives are itchy, burning swellings that appear on the skin as an indication of an allergic sensitivity to various allergens specially with a family history. The development of Urticaria occurs when the body releases histamines into the blood stream or tissues as an allergic response causing widening of the capillaries thereby allowing the plasma to escape through its walls resulting in swellings on skin surface.

Urticaria appears as red/white blotches on the skin accompanied by itching & burning. Bakson’s Urtica Aid helps relieve intolerable itching, stinging pains of Hives/Urticaria & symptoms of Angioedema besides fighting ill effects of suppressed Urtiaria.

Composition: Urtica urens 3x, Apis mellifica 3x.

Indications: Helps relieve intolerable itching, stinging pains of Hives/Urticaria & symptoms of Angioedema besides fighting ill effects of suppressed Urticaria.

Dosage: For Hives: Adults: Depending upon the condition of the complaint the dosage varies

  • Acute Phase: One tablet 4 times a day. As condition improves gradually reduce the dosage from 4 to 3, to 2, to 1 tablet at an interval of 2 -3 days and eventually maintain the dosage to one tablet twice a week (once on Monday & Thursday).
  • Chronic Phase: Start with one tablet Monday & Thursday, twice a week for two weeks. Improvement is seen, as swelling, redness and itching of skin reduces. Continue the medicine till the symptoms disappear. In case of no improvement after fifteen days you may increase to one tablet alternate day for two weeks.

Based upon the response after one month the dosages can be increased in case of no improvement which is very rare from alternate day to once a day, up to twice daily at the interval of 15 days each. Usually most of the patients respond well within the first month.

Maintenance dosage of twice a week is to be taken till patient is completely symptom free.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “BAKSONS URTICA AID TABLETS”

Your email address will not be published. Required fields are marked *